Volunteer Assignments and Opportunities: Difference between revisions
| [checked revision] | [checked revision] |
No edit summary |
No edit summary |
||
| Line 1,210: | Line 1,210: | ||
|SP (prior AE) | |SP (prior AE) | ||
|- | |- | ||
|Follicular Lymphoma||Disease||Ruthann Pfau | |Follicular Lymphoma||Disease||Updating by Rachel Burnside; Ruthann Pfau | ||
| | |7/28/2024 | ||
| | | | ||
|PENDING | |PENDING | ||
| Line 1,217: | Line 1,217: | ||
|SG | |SG | ||
| | | | ||
|SP (prior AE) | |SP (prior AE); has prior content in old template but same name in 5th edition - Rachel working on this outside of production site with new template to replace production site page later) | ||
|- | |- | ||
| Testicular Follicular Lymphoma|| ||to be deleted | | Testicular Follicular Lymphoma|| ||to be deleted | ||
| Line 1,235: | Line 1,235: | ||
|SG | |SG | ||
| | | | ||
|SP (prior AE); 2021 template added | |SP (prior AE); 2021 template added (no prior content; name to 5th edition version of In Situ Follicular B-cell Neoplasm will be changed later but Rachel working on 5th edition content in this production site) | ||
|- | |- | ||
| Duodenal-Type Follicular Lymphoma||Disease||Rachel Burnside | | Duodenal-Type Follicular Lymphoma||Disease||Rachel Burnside | ||
| Line 1,244: | Line 1,244: | ||
|SG | |SG | ||
| | | | ||
|SP (prior AE); 2021 template added | |SP (prior AE); 2021 template added (name same in 5th edition version and no prior content; Rachel working on 5th edition content in this production site) | ||
|- | |- | ||
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee) | |Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee) | ||
| Line 1,764: | Line 1,764: | ||
|SP (prior AE) | |SP (prior AE) | ||
|- | |- | ||
| Angioimmunoblastic T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee) | | Angioimmunoblastic T-cell Lymphoma||Disease||Updating by Rachel Burnside; Ruthann Pfau, Sara Akhavanfard (trainee) | ||
| | |7/28/2023 | ||
| | | | ||
|PENDING | |PENDING | ||
| Line 1,771: | Line 1,771: | ||
|SK | |SK | ||
| | | | ||
|SP (prior AE) | |SP (prior AE); (has prior content and name will change in 5th edition - Rachel working on this outside of production site to be replaced later by Nodal TFH Cell Lymphoma, Angioimmunoblastic-Type) | ||
|- | |- | ||
| Follicular T-cell Lymphoma||Disease|| | | Follicular T-cell Lymphoma||Disease||Rachel Burnside | ||
| | |7/28/2023 | ||
| | | | ||
|PENDING | |PENDING | ||
| Line 1,780: | Line 1,780: | ||
|SK | |SK | ||
| | | | ||
|SP (prior AE) | |SP (prior AE); 2021 template added (name to 5th edition version of Nodal TFH Cell Lymphoma, Follicular-Type will be changed later but Rachel working on 5th edition content in this production site) | ||
|- | |- | ||
| Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype||Disease||Hans Hamnvåg | | Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype||Disease||Hans Hamnvåg | ||